Furosemide 40 mg tablet
Public data on furosemide from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
NADAC per unit, monthly
FUROSEMIDE 40 MG TABLETShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 0.01116 |
| 2014-02 | 0.01111 |
| 2014-05 | 0.01043 |
| 2014-08 | 0.01081 |
| 2014-11 | 0.01308 |
| 2015-02 | 0.01184 |
| 2015-05 | 0.01279 |
| 2015-08 | 0.01285 |
| 2015-11 | 0.01448 |
| 2016-02 | 0.01251 |
| 2016-05 | 0.01339 |
| 2016-08 | 0.01457 |
| 2016-11 | 0.01558 |
| 2017-02 | 0.01428 |
| 2017-05 | 0.01907 |
| 2017-08 | 0.01985 |
| 2017-11 | 0.03627 |
| 2018-02 | 0.03149 |
| 2018-05 | 0.02855 |
| 2018-08 | 0.03083 |
| 2018-11 | 0.03344 |
| 2019-02 | 0.03182 |
| 2019-05 | 0.03155 |
| 2019-08 | 0.03062 |
| 2019-11 | 0.02882 |
| 2020-02 | 0.02891 |
| 2020-05 | 0.02865 |
| 2020-08 | 0.03168 |
| 2020-11 | 0.03281 |
| 2021-02 | 0.03411 |
| 2021-05 | 0.03464 |
| 2021-08 | 0.03525 |
| 2021-11 | 0.03238 |
| 2022-02 | 0.03231 |
| 2022-05 | 0.03331 |
| 2022-08 | 0.03235 |
| 2022-11 | 0.03293 |
| 2023-02 | 0.03255 |
| 2023-05 | 0.03059 |
| 2023-08 | 0.03131 |
| 2023-11 | 0.03224 |
| 2024-02 | 0.03272 |
| 2024-05 | 0.03067 |
| 2024-08 | 0.03187 |
| 2024-11 | 0.02961 |
| 2025-02 | 0.02992 |
| 2025-05 | 0.03288 |
| 2025-08 | 0.03239 |
| 2025-11 | 0.03229 |
| 2026-02 | 0.03203 |
| 2026-05 | 0.03170 |
| 2026-08 | 0.02964 |
| 2026-11 | 0.02876 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning furosemide
openFDA enforcement records, by year reported.
| 2026 | 2 |
| 2018 | 1 |
| 2017 | 1 |
| 2015 | 4 |
| 2013 | 5 |
| 2012 | 1 |
14 records since 2012. A record is one product or lot, not one recall event. Combination products that contain furosemide are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention furosemide
10 GxRadar articles cite or discuss this drug.
The generics that cost pharmacies more than they did in 2014
Most generics in GxRadar's 47-drug basket got cheaper. Seven cost pharmacies more than in January 2014, led by furosemide at 2.8 times its 2014 price. What federal cost and shortage data show, drug by drug.
FDA's essential medicines list, and what happened to it
A 2020 executive order had FDA list the medicines the US must always have. HHS later cut it to 86, Medicare now pays for stockpiles of them, and a third of today's shortages are on the original list.
FDA's current drug shortages, by therapeutic area and dosage form
Of 69 drugs FDA listed as in shortage on Oct. 30, 2026, 49 were injections. Anesthesia, pain, IV nutrition and pediatric hospital drugs dominate, and the pills are mostly ADHD stimulants.
The 505(b)(2) pathway, between brand and generic
How FDA's hybrid new drug application works, how it differs from a full NDA and a generic ANDA, and what three years of approval data show about who uses it.
The GxRadar generic price index
We priced a fixed basket of 43 common generics every month since January 2014. By October 2026 the index stood at 47.4, down about 53 percent. How it works, and where it can mislead.
What to ask when your medicine is in shortage
How FDA publishes shortage information, what the agency can and cannot do about it, and the questions that help a pharmacist and prescriber work out the next fill.